These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33494623)

  • 1. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Permeability on the Biopredictive Dissolution of Amorphous Solid Dispersions.
    Ramachandran G; Sudheesh MS
    AAPS PharmSciTech; 2021 Sep; 22(7):243. PubMed ID: 34595565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption.
    Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S
    Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Supersaturation and Phase Behavior of Ezetimibe Amorphous Solid Dispersions upon Dissolution in Different Biorelevant Media.
    Elkhabaz A; Sarkar S; Dinh JK; Simpson GJ; Taylor LS
    Mol Pharm; 2018 Jan; 15(1):193-206. PubMed ID: 29161509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
    Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
    Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
    Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
    Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
    J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of increased bioavailability through amorphous solid dispersions: a review.
    Schittny A; Huwyler J; Puchkov M
    Drug Deliv; 2020 Dec; 27(1):110-127. PubMed ID: 31885288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Artificial Gut/Absorption Simulator: Understanding the Impact of Absorption on In Vitro Dissolution, Speciation, and Precipitation of Amorphous Solid Dispersions.
    Jain KMH; Hou HH; Siegel RA
    Mol Pharm; 2024 Apr; 21(4):1884-1899. PubMed ID: 38512389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorptive Dissolution Testing: An Improved Approach to Study the Impact of Residual Crystallinity on the Performance of Amorphous Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    J Pharm Sci; 2020 Mar; 109(3):1312-1323. PubMed ID: 31765652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.